Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
52-week randomized double-blind placebo-controlled study of nalmefene as-needed in alcohol dependence
2007-002315-92Phase 3Completed
- Sponsor
- Lundbeck
- Start
- Sep 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in alcohol dependence and alcohol use disorder (AUD) comparing Nalmefene as-needed with Placebo as-needed (2 arms). Primary endpoint: Safety endpoints. Started Sep 2008; status: completed.
02
Drugs
nalmefene
03
Conditions
alcohol dependencealcohol use disorder (AUD)
Beyond the preview
Go deeper on 2007-002315-92.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-002315-92.